Region: Global
Category: Diagnostics

Global Diagnostics

(6,680 reports matching your criteria)
  • Zika Virus Testing

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More

  • Dental Diagnostic Imaging Equipment

    ... 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Intraoral Imaging Systems, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by ... Read More

  • Brachytherapy

    ... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More

  • Veterinary CT Scanners

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Stationary Multi Slice CT Scanners, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$175.7 Million by ... Read More

  • Rapid Medical Diagnostic Kits

    ... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More

  • Veterinary Ultrasound Scanners

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Portable Ultrasound Scanners, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$327.4 Million by the end ... Read More

  • Flow Chemistry

    ... CAGR of 8.8% over the analysis period 2024-2030. CSTR, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More

  • Drug Abuse Testing

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$52.0 Billion by the end of ... Read More

  • Industrial Microbiology

    ... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More

  • Inorganic Scintillators

    ... CAGR of 5.5% over the analysis period 2024-2030. Sodium Iodide (NaI) Scintillation Material, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$200.2 Million by the end ... Read More

  • Leukapheresis

    ... 7.0% over the analysis period 2024-2030. Leukapheresis Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth ... Read More

  • Life Science Instrumentation

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of ... Read More

  • Plasma Fractionation

    ... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More

  • Pneumonia Testing

    ... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More

  • In Vitro Toxicology Testing

    ... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More

  • Histology and Cytology

    ... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More

  • X-Ray Photoelectron Spectroscopy

    ... at a CAGR of 4.8% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by the end of ... Read More

  • Cervical Dysplasia Diagnostics

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More

  • Cerebral Angiography

    ... CAGR of 6.6% over the analysis period 2024-2030. Magnetic Resonance Angiography Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$36.8 Million by the end of ... Read More

  • Medical Image Analysis Software

    ... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Integrated Software, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the ... Read More

  • Immunofluorescence Assays

    ... CAGR of 4.4% over the analysis period 2024-2030. Immunofluorescence Assay Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the ... Read More

  • Mycotoxin Testing

    ... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of ... Read More

  • Nuclear Medicine Radioisotope

    ... at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m) Radioisotope, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end ... Read More

  • Sepsis Diagnostics

    ... CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis ... Read More

  • Cell Analysis

    ... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings